Welcome to our dedicated page for Perrigo Co Plc news (Ticker: PRGO), a resource for investors and traders seeking the latest updates and insights on Perrigo Co Plc stock.
Perrigo Company plc (NYSE: PRGO) is a pure-play self-care and consumer health company whose news flow is closely tied to its over-the-counter (OTC) product portfolio, category performance and strategic initiatives. The company regularly issues updates on its Consumer Self-Care Americas and Consumer Self-Care International segments, highlighting trends in categories such as Upper Respiratory, Pain & Sleep Aids, Digestive Health, Nutrition, Vitamins, Minerals and Supplements, Women’s Health, Skin Care, Oral Care and Healthy Lifestyle.
On this page, readers can follow Perrigo’s earnings announcements, where the company discusses net sales, organic growth, segment performance and the impact of divestitures and exited products. These releases often reference store brand market share gains in OTC categories, performance of key brands and progress under its Three-S plan (Stabilize, Streamline, Strengthen). Updates on Project Energize, the global investment and efficiency program designed to support the One Perrigo growth strategy, are also a recurring theme in recent communications.
Perrigo’s news also covers portfolio actions and strategic reviews. The company has disclosed an agreement to sell its Dermacosmetics branded business in certain European markets and has announced strategic reviews of its Oral Care and infant formula businesses. In addition, readers will find announcements related to dividends, participation in investor conferences and brand-level initiatives, such as collaborations involving Opill®, which Perrigo describes as the first daily birth control pill available without a prescription in the United States.
Investors, analysts and consumers can use this news feed to monitor how Perrigo is positioning its OTC and self-care portfolio, how its store brand and branded businesses are performing across regions and categories, and how management is adjusting the company’s structure and investments in response to market conditions.
Perrigo Company plc (NYSE; TASE: PRGO) announced on June 17, 2020, a strategic investment in Kazmira LLC to enter the rapidly expanding CBD market. The deal includes a minority equity stake of approximately 20% for $50 million, aimed at producing THC-free CBD through a two-phase partnership. The first phase will enhance Kazmira's facilities to meet high-quality standards, while the second phase will launch CBD products in global markets. This collaboration aligns with Perrigo's vision to provide trusted self-care products and is expected to drive long-term growth for shareholders.
Perrigo Company plc announced a public offering of $750 million in 3.150% Senior Notes due 2030, priced at 99.170% of the principal amount. These notes will be fully guaranteed by Perrigo and are intended to fund the redemption of existing 3.500% Senior Notes due in 2021. The offering is expected to close on June 19, 2020, subject to customary conditions. This move aims to optimize financial costs by replacing higher interest debt with lower interest notes, thereby enhancing Perrigo's financial flexibility.
Perrigo Company plc (NYSE: PRGO) announced a public offering of senior notes by its wholly-owned finance subsidiary, Perrigo Finance Unlimited Company. The offering will fund the redemption of existing senior notes due in 2021, with any remaining proceeds allocated for general corporate purposes. The offering is dependent on market conditions, with BofA Securities, J.P. Morgan, and Wells Fargo Securities serving as joint book-running managers. The company emphasizes that this press release does not constitute an offer to sell securities.